Sources | Names Used |
---|---|
CTRPv2 | BRD-K61166597 |
PharmacoGx | BRD-K61166597 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HRASLS | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
mRNA | PABPC4L | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
mRNA | AP5S1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
mRNA | ROCK2 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
mRNA | BRD1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
mRNA | C11orf91 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
mRNA | PDXP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | POLE3 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
mRNA | CLNS1A | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
mRNA | TTPAL | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |